首页|异常DNA甲基化在慢性髓系白血病中的临床应用

异常DNA甲基化在慢性髓系白血病中的临床应用

扫码查看
DNA甲基化是一种人体内重要的生物化学过程,即在不改变DNA序列的情况下,基因表达发生可稳定遗传的变化.DNA甲基化状态的改变与众多生物过程有着紧密的关联,涵盖细胞增殖、细胞分化、胚胎发育、免疫性疾病及肿瘤的发生和发展等诸多生理和病理活动.特别是,异常DNA甲基化在慢性髓系白血病(chronic myeloid leukemia,CML)的发生、进程和预后中起关键作用.DNA甲基化在CML的诊断及治疗上显示出巨大潜力.深入了解DNA甲基化的具体机制,尤其是在CML患者中特定基因的DNA甲基化异常改变,有助于推动以DNA甲基化为基础的新型靶向治疗策略进入临床实践,从而有效地诊断并治疗CML患者.
Clinical applications of abnormal DNA methylation in chronic myeloid leukemia
DNA methylation,a crucial biochemical process within the human body,fundamentally alters gene expression without modifying the DNA sequence,resulting in stable changes.The changes in DNA methylation are closely related to numerous biological processes including cellular proliferation and differentiation,embryonic development,and the occurrence of immune diseases and tumor.Specifically,abnormal DNA methylation plays a crucial role in the formation,progression,and prognosis of chronic myeloid leukemia(CML).Moreover,DNA methylation offers substantial potential for diagnosing and treating CML.Accordingly,understanding the precise mechanism of DNA methylation,particularly abnormal changes in the methylation of specific genes in CML,can potentially promote the development of novel targeted therapeutic strategies.Such strategies could transform into clinical practice,effectively aiding diagnosis and treatment of CML patients.

chronic myeloid leukemiaDNA methylationdemethylation drugsepigenetics

周灵艳、殷小成

展开 >

南华大学衡阳医学院附属第一医院儿科,湖南 衡阳 421600

慢性髓系白血病 DNA甲基化 去甲基化药物 表观遗传学

国家自然科学基金湖南省自然科学基金

3127148220201977

2024

中南大学学报(医学版)
中南大学

中南大学学报(医学版)

CSTPCD北大核心
影响因子:1.459
ISSN:1672-7347
年,卷(期):2024.49(1)
  • 38